Financials
- Market Capitalization 548.14 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.94
Relación precio/flujo de caja
100.37
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2860 | DRUG Bright Minds Biosciences Inc. - common stock | 72.81 USD | -2.32% | -5.50% | +1.70% | +85.83% | 555.96 M USD | ||
| 2863 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.83 USD | +0.55% | +15.09% | +19.61% | -12.02% | 553.25 M USD | ||
| 2865 | OVID Ovid Therapeutics Inc. - Common Stock | 2.80 USD | -4.44% | +0.36% | +21.74% | +124.00% | 546.83 M USD | ||
| 2870 | ARTV Artiva Biotherapeutics, Inc. - Common Stock | 11.09 USD | -7.12% | +2.40% | +10.90% | +166.59% | 542.19 M USD |